Unknown PHASE1 INTERVENTIONAL 2-arm NCT05054868

Ketorolac vs Oxycodone for Great Toe Arthrodesis

Effect of Ketorolac Administration on Post-operative Narcotic Utilization and Union Rates in Great Toe Arthrodesis

Sponsor: Medstar Health Research Institute

Updated 6 times since 2021 Last updated: Jul 11, 2023 Started: Apr 14, 2020 Primary completion: Jul 31, 2024 Completion: Jul 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Arthrodesis and is currently ongoing. Medstar Health Research Institute leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Aug 2025 — Present [monthly]

Unknown PHASE1

Status: Recruiting → Unknown
Sep 2024 — Aug 2025 [monthly]

Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Aug 2023 — Jul 2024 [monthly]

Recruiting PHASE1
Jul 2022 — Aug 2023 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Oct 2021 — Jul 2022 [monthly]

Recruiting PHASE1

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medstar Health Research Institute

Data source: Medstar Health Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States